Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$57.94
+0.9%
$55.93
$39.65
$58.28
$43.62B1.123.99 million shs3.22 million shs
IAM
Integrated Asset Management
C$2.74
C$1.52
C$2.92
C$75.96MN/A30,209 shs8,780 shs
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.44
-4.4%
$0.00
$0.25
$0.91
$29.33M1.71803,206 shs428,730 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
+0.51%+6.42%+1.74%+4.63%+31.01%
IAM
Integrated Asset Management
0.00%0.00%0.00%0.00%0.00%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.00%0.00%0.00%+6.36%-13.85%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
4.764 of 5 stars
2.35.04.22.12.62.52.5
IAM
Integrated Asset Management
N/AN/AN/AN/AN/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
2.56
Moderate Buy$60.173.84% Upside
IAM
Integrated Asset Management
N/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/A

Current Analyst Ratings

Latest VIN, IAM, RMMC, BK, and IGC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$62.00 ➝ $63.00
4/18/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$67.00 ➝ $68.00
4/17/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$64.00 ➝ $66.00
4/4/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$57.00 ➝ $61.00
3/27/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$58.00
2/14/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$60.00 ➝ $65.00
1/30/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$52.00 ➝ $62.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$33.81B1.29$7.96 per share7.28$48.26 per share1.20
IAM
Integrated Asset Management
C$18.31M0.00N/A4.43C$0.67 per share0.00
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$910K32.23N/AN/A$0.28 per share1.57

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$3.29B$4.1014.139.711.239.48%11.80%1.02%7/16/2024 (Estimated)
IAM
Integrated Asset Management
N/AC$0.1124.91N/AN/AN/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-$11.51M-$0.26N/AN/A-1,163.24%-110.37%-93.34%N/A

Latest VIN, IAM, RMMC, BK, and IGC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q1 24
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$1.19$1.29+$0.10$1.33$4.39 billion$4.53 billion    
2/14/2024Q3 2024
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/A-$0.09-$0.09-$0.09N/A$0.20 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$1.682.90%+8.41%40.98%13 Years
IAM
Integrated Asset Management
C$0.11N/AN/A100.00%N/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/A

Latest VIN, IAM, RMMC, BK, and IGC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
quarterly$0.423.05%4/25/20244/26/20245/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
0.90
0.71
0.72
IAM
Integrated Asset Management
N/A
4.85
4.81
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.02
1.85
0.86

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
85.31%
IAM
Integrated Asset Management
N/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.87%

Insider Ownership

CompanyInsider Ownership
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
0.14%
IAM
Integrated Asset Management
N/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
19.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
53,400752.87 million751.82 millionOptionable
IAM
Integrated Asset Management
5627.72 millionN/ANot Optionable
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
6166.81 million54.12 millionNot Optionable

VIN, IAM, RMMC, BK, and IGC Headlines

SourceHeadline
IGC Pharma (NYSEAMERICAN:IGC) Now Covered by Analysts at StockNews.comIGC Pharma (NYSEAMERICAN:IGC) Now Covered by Analysts at StockNews.com
americanbankingnews.com - April 24 at 2:32 AM
Phase II miss in PD cognitive impairment clips SagePhase II miss in PD cognitive impairment clips Sage
bioworld.com - April 18 at 3:26 PM
IGC Pharma (NYSEAMERICAN:IGC) Coverage Initiated by Analysts at StockNews.comIGC Pharma (NYSEAMERICAN:IGC) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - April 18 at 2:22 AM
CDC investigating reports of counterfeit or mishandled Botox injections in 9 statesCDC investigating reports of counterfeit or mishandled Botox injections in 9 states
msn.com - April 17 at 8:41 AM
Short Interest in IGC Pharma, Inc. (NYSEAMERICAN:IGC) Expands By 10.6%Short Interest in IGC Pharma, Inc. (NYSEAMERICAN:IGC) Expands By 10.6%
americanbankingnews.com - April 17 at 1:48 AM
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimers-Associated AgitationIGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
benzinga.com - April 16 at 12:42 PM
IGC-AD1s Interim Phase 2 Data Show a Reduction in Alzheimers Agitation at Week TwoIGC-AD1's Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two
stockhouse.com - April 16 at 7:41 AM
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week TwoIGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
finance.yahoo.com - April 16 at 7:41 AM
IGC Pharma (NYSEAMERICAN:IGC) Coverage Initiated at StockNews.comIGC Pharma (NYSEAMERICAN:IGC) Coverage Initiated at StockNews.com
americanbankingnews.com - April 14 at 2:18 AM
IGC Pharma Inc.IGC Pharma Inc.
barrons.com - April 9 at 9:04 PM
IGC Pharma Adds Advisor in Artificial IntelligenceIGC Pharma Adds Advisor in Artificial Intelligence
businesswire.com - April 9 at 9:00 AM
Headbangers Rhythm Royale Season Three Out NowHeadbangers Rhythm Royale Season Three Out Now
invisioncommunity.co.uk - April 4 at 1:27 PM
Uzbek envoy speaks of Punjab’s economic ‘preponderance’Uzbek envoy speaks of Punjab’s economic ‘preponderance’
brecorder.com - April 4 at 1:27 PM
IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimers ResearchIGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research
benzinga.com - April 2 at 10:19 AM
All About Kyle Richards Mom Kathleen RichardsAll About Kyle Richards' Mom Kathleen Richards
msn.com - March 28 at 8:37 AM
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common StockIGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
businesswire.com - March 26 at 3:00 PM
Alzheimers-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To PlaceboAlzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
msn.com - March 20 at 5:06 PM
EXCLUSIVE: Revolutionary Alzheimers Drug By IGC Shows Early SuccessEXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
msn.com - March 20 at 5:06 PM
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s AgitationIGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
finance.yahoo.com - March 20 at 12:06 PM
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimers AgitationIGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation
businesswire.com - March 20 at 11:00 AM
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
businesswire.com - March 20 at 7:00 AM
Belarussian FM, Union minister Piyush Goyal highlight need to create awareness on business opportunities in two countriesBelarussian FM, Union minister Piyush Goyal highlight need to create awareness on business opportunities in two countries
news.webindia123.com - March 14 at 9:38 AM
Belarusian FM talks trade, economy, SCO cooperation in IndiaBelarusian FM talks trade, economy, SCO cooperation in India
thehansindia.com - March 14 at 9:38 AM
Going the Last Mile (with Evidence)Going the Last Mile (with Evidence)
insights.som.yale.edu - March 13 at 2:33 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bank of New York Mellon logo

Bank of New York Mellon

NYSE:BK
The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. The company operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing and payables management, and trade finance and processing services. The Investment and Wealth Management segment offers investment management strategies and distribution of investment products, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment engages in the provision of leasing, corporate treasury, derivative and other trading, corporate and bank-owned life insurance, renewable energy investment, and business exit services. It serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

Integrated Asset Management

TSE:IAM
Integrated Asset Management Corp. operates as an alternative asset investment management company. The company provides investors with private equity, private corporate debt, managed futures, hedge funds, real estate investment management, property management and leasing, and merchant banking. It offers alternative asset class management to institutional, pension, and private clients. Integrated Asset Management Corp. was founded in 1998 and is headquartered in Toronto, Canada.
IGC Pharma logo

IGC Pharma

NYSEAMERICAN:IGC
IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.